跳至主要内容
临床试验/NCT02117921
NCT02117921已完成不适用

Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
SF-12 Health Survey Scoring Demonstration

研究概览

简要总结

To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient 18 > years old
  • Chronic pain without clear organic etiology after full evaluation by primary care physician or subspecialist
  • Pain persistent for a minimum of 3 days a week for the past three months prior to enrollment

排除标准

  • Patients < 18 years of age
  • Diagnosed organic disease as cause of pain, such as but not limited to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis)
  • Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia and bi-polar disorder. Mild to moderate depression and anxiety will not be considered as exclusions
  • Pregnancy
  • Severe depression or recent suicide attempt

结局指标

主要结局

SF-12 Health Survey Scoring Demonstration

时间窗: 4 weeks

Brief Pain Inventory Questionnaire

时间窗: 4 weeks

To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.

次要结局

  • SF-12 Health Survey Scoring Demonstration and Brief Pain Inventory Score(2 weeks, 4 weeks, 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Donnino

Michael W. Donnino, MA

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验